• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用粉末流变学和渗透性预测干粉吸入器性能的能力和局限性。

Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance.

机构信息

Department of Pharmaceutics and Biopharmaceutics, Christian Albrecht University, Gutenbergstrasse 76, Kiel, Germany.

出版信息

Eur J Pharm Biopharm. 2012 Oct;82(2):417-23. doi: 10.1016/j.ejpb.2012.07.018. Epub 2012 Aug 9.

DOI:10.1016/j.ejpb.2012.07.018
PMID:22902789
Abstract

Dry powder inhalers play a major role in today's treatment of various respiratory diseases. A lot of effort has been put into the optimization of a device and the appropriate formulation regarding its local lung deposition. However, the complexity and interactions of different factors governing powder dispersion and, therefore, its inhalable fraction challenge research groups around the world. In the current work, binary lactose blends and adhesive ternary powder mixtures containing additional budesonide fines were produced and analyzed with dispersion measurements on the one hand and permeability and aeration measurements conducted with a powder rheometer on the other hand. By comparing the results of the bulk property and dispersion tests, it was expected to gain a better understanding about the effect of excipient fines addition to an adhesive powder mixture. It could be observed that with permeability testing it was possible to clearly differentiate between different amounts of fines within mixtures. However, no correlation between permeability or aeration test values and drug fine particle fraction could be determined for the observed range. Nevertheless, the use of different characterization techniques led to a clearer understanding about the influence of fines addition to an adhesive mixture. It could be demonstrated that after the surface of carrier crystals had been fully saturated, drug particles got incorporated in more stable fines' agglomerates, which resulted in a decrease in fine particle fraction upon dispersion.

摘要

干粉吸入器在当今治疗各种呼吸道疾病方面发挥着重要作用。人们在设备优化和适当制剂方面付出了大量努力,以提高其肺部局部沉积率。然而,控制粉末分散的各种因素的复杂性和相互作用,以及由此产生的可吸入部分,给世界各地的研究小组带来了挑战。在当前的工作中,生产了含有额外布地奈德细粉的二元乳糖混合物和粘性三元粉末混合物,并通过分散测量一方面和使用粉末流变法进行的渗透性和通气性测量另一方面进行了分析。通过比较体积性质和分散测试的结果,希望能够更好地了解赋形剂细粉添加到粘性粉末混合物中的影响。可以观察到,通过渗透性测试,可以清楚地区分混合物中不同量的细粉。然而,对于观察到的范围,无法确定渗透性或通气性测试值与药物细颗粒分数之间的相关性。尽管如此,使用不同的表征技术可以更清楚地了解赋形剂细粉添加到粘性混合物中的影响。可以证明,在载体晶体的表面完全饱和后,药物颗粒被纳入更稳定的细粉团聚体中,这导致分散后细颗粒分数降低。

相似文献

1
Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance.利用粉末流变学和渗透性预测干粉吸入器性能的能力和局限性。
Eur J Pharm Biopharm. 2012 Oct;82(2):417-23. doi: 10.1016/j.ejpb.2012.07.018. Epub 2012 Aug 9.
2
Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.粉末透气度:干粉吸入器制剂开发的潜在工具。
Eur J Pharm Biopharm. 2010 Nov;76(3):464-9. doi: 10.1016/j.ejpb.2010.09.003. Epub 2010 Sep 18.
3
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.干粉吸入剂中的空气分级器技术(ACT) 第4部分。Novolizer多剂量干粉吸入器中空气分级器技术的性能。
Int J Pharm. 2006 Mar 9;310(1-2):81-9. doi: 10.1016/j.ijpharm.2005.11.029. Epub 2006 Jan 25.
4
Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.硬脂酸镁和细乳糖协同作用改善丙酸氟替卡松干粉制剂的雾化性能。
Int J Pharm. 2024 Oct 25;664:124609. doi: 10.1016/j.ijpharm.2024.124609. Epub 2024 Aug 18.
5
Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.载体微观结构在基于粘合剂/载体的干粉吸入混合物中的作用洞察:载体孔隙率和细颗粒含量。
Eur J Pharm Biopharm. 2015 Oct;96:291-303. doi: 10.1016/j.ejpb.2015.08.006. Epub 2015 Aug 11.
6
Low powder mass filling of dry powder inhalation formulations.干粉吸入制剂的低粉量填充。
Drug Dev Ind Pharm. 2011 Jan;37(1):24-32. doi: 10.3109/03639045.2010.489561. Epub 2010 Aug 12.
7
Entrainment of lactose inhalation powders: a study using laser diffraction.乳糖吸入粉的夹带:使用激光衍射的研究。
Eur J Pharm Sci. 2010 Jul 11;40(4):352-8. doi: 10.1016/j.ejps.2010.04.009. Epub 2010 Apr 24.
8
Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.粉末流动分析:一种指示干粉吸入剂配方中乳糖细粉理想量的简单方法。
Int J Pharm. 2018 Jan 15;535(1-2):59-67. doi: 10.1016/j.ijpharm.2017.10.052. Epub 2017 Oct 31.
9
Modeling dispersion of dry powders for inhalation. The concepts of total fines, cohesive energy and interaction parameters.干粉吸入剂的分散模型。总细粉、内聚能和相互作用参数的概念。
Int J Pharm. 2012 May 10;427(2):224-33. doi: 10.1016/j.ijpharm.2012.02.009. Epub 2012 Feb 14.
10
Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.丙酸氟替卡松在干粉吸入剂制剂中的聚集行为。
Eur J Pharm Biopharm. 2012 Apr;80(3):596-603. doi: 10.1016/j.ejpb.2011.12.004. Epub 2011 Dec 14.

引用本文的文献

1
Packing and flow performance of binary adhesive mixtures for inhalation of different drug loads and their relationships to aerosolisation.不同药物载量吸入用二元粘合剂混合物的填充和流动性能及其与雾化的关系。
Int J Pharm X. 2025 Jul 17;10:100358. doi: 10.1016/j.ijpx.2025.100358. eCollection 2025 Dec.
2
Optimization of Carrier-Based Dry Powder Inhaler Performance: A Review.基于载体的干粉吸入器性能优化:综述
Pharmaceutics. 2025 Jan 13;17(1):96. doi: 10.3390/pharmaceutics17010096.
3
Potential of Powder Rheology for Detecting Unforeseen Cross-Contamination of Foreign Active Pharmaceutical Ingredients.
粉末流变学在检测外来活性药物成分意外交叉污染方面的潜力。
AAPS PharmSciTech. 2024 Jun 18;25(6):138. doi: 10.1208/s12249-024-02856-0.
4
Process Model Approach to Predict Tablet Weight Variability for Direct Compression Formulations at Pilot and Production Scale.中试和生产规模下直接压片制剂片剂重量变异预测的过程模型方法
Pharmaceutics. 2021 Jul 7;13(7):1033. doi: 10.3390/pharmaceutics13071033.
5
Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia.高剂量磷酸奥司他韦干粉吸入疗法用于病毒性肺炎的研发
Pharmaceutics. 2020 Nov 27;12(12):1154. doi: 10.3390/pharmaceutics12121154.
6
Moisture-Resistant Co-Spray-Dried Netilmicin with l-Leucine as Dry Powder Inhalation for the Treatment of Respiratory Infections.以L-亮氨酸为辅料的防潮共喷雾干燥奈替米星干粉吸入剂治疗呼吸道感染
Pharmaceutics. 2018 Dec 1;10(4):252. doi: 10.3390/pharmaceutics10040252.
7
The Effects of Relative Humidity on the Flowability and Dispersion Performance of Lactose Mixtures.相对湿度对乳糖混合物流动性和分散性能的影响
Materials (Basel). 2017 May 29;10(6):592. doi: 10.3390/ma10060592.
8
An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.细乳糖颗粒对载体型干粉吸入剂配方的流化行为和气雾化性能影响的研究。
AAPS PharmSciTech. 2014 Aug;15(4):898-909. doi: 10.1208/s12249-014-0119-6. Epub 2014 Apr 23.